ALEC Projected Dividend Yield
Alector Inc ( NASDAQ : ALEC )Alector is a clinical stage biopharmaceutical company developing immuno-neurology, a therapeutic approach for the treatment of neurodegeneration. Co.'s product candidate, AL001, modulates progranulin (PRGN), a key regulator of immune activity in the brain with genetic links to multiple neurodegenerative disorders. AL101, Co.'s second product candidate in its PGRN portfolio, is designed to treat people suffering from more prevalent neurodegenerative diseases. AL003 is Co.'s second therapeutic candidate designed to treat patients with Alzheimer's disease. AL044 is Co.'s therapeutic candidate for neurodegeneration. 20 YEAR PERFORMANCE RESULTS |
ALEC Dividend History Detail ALEC Dividend News ALEC Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |